insights_auto
Per què SOBI ha pujat 2,64%?
Aprofundeix méschevron_right
SOBI:STO
Swedish Orphan Biovitrum AB (publ)
458,40Â SEK
arrow_upward
+2,64%(+11,80) 1d
21 d’oct., 17:29:42 GMT+2 · SEK
search
Tots els sÃmbols
| SÃmbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadÃstiques principals per a SOBI...
Obre
446,60Â SEK
Alt
458,40Â SEK
Baix
445,60Â SEK
Capitalització borsà ria
163,94Â kM
Volum mitjÃ
259,17Â k
Volum
0,00
RÃ tio preu-benefici
122,43
Alt 52 setmanes
487,00Â SEK
Baix 52 setmanes
310,60Â SEK
BPA
3,74Â SEK
Accions en circulació
357,64Â M
Nombre d'empleats
2Â k
Obre
446,60Â SEK
Alt
458,40Â SEK
Baix
445,60Â SEK
Capitalització borsà ria
163,94Â kM
Volum mitjÃ
259,17Â k
Volum
0,00
RÃ tio preu-benefici
122,43
Alt 52 setmanes
487,00Â SEK
Baix 52 setmanes
310,60Â SEK
BPA
3,74Â SEK
Accions en circulació
357,64Â M
Nombre d'empleats
2Â k
NotÃcies
De fonts web i partners de notÃcies
Simply Wall Street
·
fa 9 minuts
Amkor Technology (AMKR) Expands South Korea Capacity For AI Chip Packaging
Moomoo
·
fa 40 minuts
Dow Jones Top Markets Headlines at 9 PM ET: SpaceX, Anthropic and Nvidia Help Snap Tech Stocks Out of Their Recent Malaise | Canada ...
MarketBeat
·
fa 21 minuts
IperionX (NASDAQ:IPX) Sets New 52-Week Low - Should You Sell?
Perfil
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Sobre Swedish Orphan Biovitrum AB (publ)